Lymphocyte Gene Therapy

Kenneth W. Culver, W. French Anderson, R. Michael Blaese

Human Gene Therapy · 1991 · 127 citations · 11 references

Concepts

Abstract

Genetically corrected T cells are currently under investigation as a treatment for severe combined immunodeficiency disease resulting from a lack of adenosine deaminase (ADA). Monthly injections of these ADA-corrected T cells have resulted in measurable ADA activity in the peripheral blood and the in vivo production of antibody to blood group antigen. Genetically corrected T cells appear to be clinically valuable vehicles for gene therapy.

References

11